In human lung cancers, GATA6 is rarely mutated, but its expression is increased in early stage non small cell lung cancer (NSCLC) relative to normal tissue and may correlate with tumor promoting genes [10, 11]. The gene discussed is GATA6; the disease is lung carcinoma.